AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
As official healthcare partner, ShardaCare deployed dedicated medical teams, emergency services, and on-site healthcare infrastructure
New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy
The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
New-generation platform enhances anatomical visualization, streamlines surgical workflows, and expands access to advanced navigation technology for ENT surgeons across Europe
The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants
The launch comes against the backdrop of a significant public health burden
Subscribe To Our Newsletter & Stay Updated